N
Neurosalience develops a tool for the early detection of dementia utilizing structural MRI and CT data. This technology employs interpretable machine learning algorithms to assess brain aging risk, even with low-resolution scans. Early risk assessment enables timely lifestyle changes, potentially slowing disease progression and reducing long-term patient care costs.
Updated 3 months ago
Funding
$310K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Neurosalience develops a tool for the early detection of dementia utilizing structural MRI and CT data. This technology employs interpretable machine learning algorithms to assess brain aging risk, even with low-resolution scans. Early risk assessment enables timely lifestyle changes, potentially slowing disease progression and reducing long-term patient care costs.